Top compounds associated with response to LGALS7B


Feature Type Standardized
Nominal ANOVA
mRNA thalidomide CTRPv2 pan-cancer AAC -0.014 0.8
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.0088 0.8
mRNA BRD-K27224038 CTRPv2 pan-cancer AAC 0.021 0.8
mRNA chlorambucil CTRPv2 pan-cancer AAC -0.008 0.8
mRNA serdemetan:SCH-529074 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.0088 0.8
mRNA BRD-A02303741 CTRPv2 pan-cancer AAC -0.0097 0.8
mRNA NSC95397 CTRPv2 pan-cancer AAC 0.0082 0.8
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.0089 0.8
mRNA neratinib CTRPv2 pan-cancer AAC 0.0086 0.8
mRNA PI-103 CTRPv2 pan-cancer AAC 0.0083 0.8
Download CSV